Ampio Pharma has a new corp sec

Mark McGregor yesterday began his new role as the chief financial officer and corporate secretary of Ampio Pharmaceuticals, a $49 million Colorado-based drug developer.

McGregor replaces Bruce Miller, who had served as the company’s CFO and corporate secretary since April 2010 and will be working toward the commercialization of a product that Ampio obtained through its acquisition of DMI BioSciences.

A certified public accountant, McGregor boasts extensive experience in several areas, including risk management and SEC reporting, according to a press release. His 30-year career includes a stint as the vice president, corporate treasurer and corporate development at Storage Technology Corporation, a public company with $2 billion in annual worldwide revenues.


You must be registered to comment.

Please Sign In or Register.

Free white paper illustrates the ping-pong of preparing an IPO with the SEC

Tactical workflow for the most important document a public company will ever produce

Vintage Filings, the financial printing, EDGAR and XBRL filing division of PR Newswire, today announced the availability of a new white paper that illustrates the collaborative workflow between a corporation and the SEC when preparing an IPO S1 file: ‘How your IPO S1 filing flows to & from the SEC’. Vintage Filings prepared this brief in response to its law firm partners and corporate clients wanting more transparency around the role a financial printer has in the process. The white paper offers a very tactical, step-by-step view.

To view the report, click here.